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Measurement of Permeability 
of the Cell Membrane to Water 
ABSTRACT-The water permeability was measured for blood cells from normal subjects and for 
blood cells from patients with leukemia. The method of measurement of the kinetics of water 
influx employed a stopped flow apparatus. The method of calculation of results was based on 
irreversible thermodynamics. The measurements and calculations were both performed with the 
assistance of a computer. The water permeability of the leukemic cells was decreased from normal, 
and the values were more variable than normal. Leukemia changes the structure of the cell 
membrane. 
RICHARD MOORE*, FREDERICK THORNBURGH** 
DONGGYU JIN*** 
Cancer represents a derangement of the normal functions 
of a cell. This derangement may affect the physiological 
properties of the cell membrane. Cancer of the blood 
(leukemia) may affect the membrane properties of circu-
lating blood cells. If there is such an alteration, it might be 
useful in predicting the response of a patient to chemo-
therapy, and hence, in selecting an effective anti-leukemic 
drug. 
Such an approach to the problem of predicting of drug 
therapy is suggested in the acute leukemias for several 
reasons. There are more drugs which are effective against 
acute leukemias than against other cancers, such as solid 
tumors. Lymphatic leukemia is very drug sensitive compared 
to other types of leukemias. Sampling neoplastic cells is 
simpler for leukemias than solid tumors. 
One of the goals of oncology is to improve the chemo-
therapy of malignant disease, such as leukemia. Often, drug 
effectiveness is evaluated on the basis of statistical considera-
tions, using data from large scale clinical trials with many 
drugs. The oncologist needs a procedure that could help 
predict which drug, if any, would have the greatest chance 
for success in the treatment of a specific patient. Ideally, 
the diagnostic procedures should work in vitro with 
micro-samples and produce results promptly. There is need 
for such a predictive test in acute myelogenous leukemia 
for example. There is a large number of c~ndidate drugs, 
and all of them cannot be tried on a patient before a 
successful one is found. Not only may the patient not 
survive long enough for several drugs to be tested, but the 
effect of a particular drug may be influenced by prior 
chemotherapy. 
For a drug to be effective at the cellular level in a lympho-
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proliferative disease, such as leukemia, the drug must enter 
the cell. Entrance may be affected by the normal perme-
ability of the cell membrane to the drug as well as the 
effect of the disease on the cell membrane permeability. 
Penetration of the drug through the cell membrane deter-
mines the response of a cell to the drug, e.g., as metho-
trexate. If methotrexate enters, the cells respond to the 
drug in cases of animal leukemia and human leukemia. 
Kessel (1969) reported that alkalating agents, busulfan and 
nitrogen mustard, entered cells, and this entrance was 
associated with the response of the cell to the drug. Kessel 
(1971) tested platelets and granulocytes from humans with 
leukemia of unspecified type. If the drug affected the 
capacity of the cells to incorporate labeled uridine or 
thymidine into RNA, then the drug administration was 
effective against the leukemia. 
To be effective, anti-leukemia drugs must be taken up 
and retained within leukemic blast cells. While within 
the cells, they should have the maxium effect on the cell. 
Vincristine is a drug useful in the treatment of acute 
leukemia, and its efficacy is determined by the perme-
ability of the cell wall. Complex procedures are necessary, 
involving assay of the radiosiotopically labeled drugs, to 
measure the concentration of the drug within the cell. We 
hope to study one of the factors (membrane permeability) 
upon which successful drug therapy depends. This paper 
describes our approach to measuring membrane perme-
ability. 
Samples from human volunteers 
Samples of peripheral blood were obtained from human 
volunteers or from patients with several types of acute 
leukemia. Two milliliters of blood were collected in EDT A 
(ethylenediaminetetracetate) anticoagulant. One volume of 
cells was mixed with 99 volumes of human blood plasma 
of the same type and group as that of the patient. Three 
milliliters of the resulting· 1 % cell suspension were placed 
in one syringe of a stopped flow apparatus, and ·a 
"challenging" solution was placed in the other syringe. The 
challenging solution was typed plasma which either was 
undiluted or was diluted with distilled water to a known 
hypo tonic concentration. All samples of plasma and distilled 
water were degassed with a vacuum pump before using. 
The appearance of selected samples of cells was examined 
microscopically before the sample entered the stopped 




A cell suspension was placed in one syringe , and a 
"challenging" solution was placed in a second syringe. The 
syringes were placed in an Aminco-Morrow stopped flow 
apparatus. To perform an experiment, compressed air forced 
aliquots from each syringe through a "T"-shaped mixer 
into an optical cuvette, and the flow was stopped. Simul-
taneously, an oscilloscope trace was initiated. Monochro-
matic light shown through the optical cuvette. The light 
was multiply scattered by the cells, and the beam emerging 
from the cuvette fell on the photocathode of a photo-
multiplier. The photomultiplier signal was amplified and 
appeared at the beam deflection plates in a storage 
oscilloscope. Water moved from the hypotonic suspension 
medium into the blood cells, increasing the cell volume. 
When the blood cell volume changed, the amount of light 
scattering varied, and the phototube signal changed accord-
ingly. A linear calibration related phototube signal to 
erythrocyte volume at equilibrium. Selected curves traced 
on the scope phosphor were photographed. The kinetics 
of cell volume change, and hence of water movement, were 
calculated from measurements of the photograph. 
Distilled water was mixed with distilled water to provide 
a reference trace. The response of the system indicated 
whether the operation of the apparatus was satisfactory. 
Instrument response was checked also by mixing two ali-
quots of a latex particle suspension, noting the resulting 
oscilloscope trace, and comparing this trace with that 
obtained on previous days. 
Procedure of experiment 
Experiments were performed in which erythrocytes were 
challenged with a hypotonic plasma. The per cent optical 
transmission was recorded as a function of time . Points 
were selected on the recorded curve , and the coordinates of 
the points were measured with a traveling microscope, and/ 
or with a coordinate reader. The coordinate reader had two 
transparent cursors which move in perpendicular directions, 
and each cursor bore a cross-hair. Each cursor was connected 
to a potentiometer across which a stable and constant D-C 
voltage was maintained. A fraction of the potentiometer 
voltage was tapped, and this fraction was proportional to 
the distance ot the cu1~or from a reference point. The 
voltages tapped from the two potentiometers were the 
input signals to two channels of a mini-computer. The com-
puter was programmed to convert the two analog voltages 
to digital signals, display the point defined by these two 
coordinates on the screen of a cathode ray tube (to help 
detect an operator's mistakes), format, and punch the 
digital values of the coordinates of the points into paper 
tape. Another program, used subsequently, read the paper 
tape , printed the data. and used calibration constants to 
scale the values to those of the ongmal photograph. The 
program calculated the logarithms of the ordinates. A 
method of data reduction was used (Frost and Pearson) 
that did not require knowledge of the asymptote which 
the curve approached. This elimination of the need to 
estimate the unknown asymptote removed a source of 
potential error from the calculations. However, this gain is 
at the cost of being able to use only half the data points 
for the regression analysis. The program performed a linear 
regression on the points. It calculated the pseudo-first 
order rate constant from the slope of the regression line, 
the corresponding half time for the cell volume change, and 
the osmotic filtration coefficient of the cell membrane. This 
12 
calculation was based on a method described by Farmer 
and Macey. 
The data set was edited by removing the measurements 
made during the first 150 milliseconds ( during which the 
phototube signal did not represent cell volume change 
only). The remaining data were fitted by the equation: 
y = sum (Bi exp (-Ki t)) + A, in which i was I , 2, and 3 
in successive calculations. 
Reproducible and nonreproducible data photos 
If erythrocytes were mixed with hypertonic medium , 
a single phase of volume change was usually seen. The first 
150 milliseconds of data on photographs usually was not 
reproducible. This was interpreted as being due to an arti-
fact of mixing. The curve at times greater than 150 milli-
seconds was reproducible. This portion of the curve was 
measured. If the measured points were plotted on semi-
logarithm paper, a single exponential usually fitted the 
experimen,tal curve. The values calculated for the osmotic 
filtration coefficient for cells from normal donors were 
reproducible and were about 0.6 microns per minute per 
atmosphere. The curves for the cells for patients with 
leukemia were more variable. Some of these curves had 
the same general shape as the curves from normal cells, 
but the associated value of the half-hme of cell swelling 
was longer, and the value of the osmotic filtration co-
efficient was generally lower than normal (3/4 of normal 
in acute lymphocytic leukemia to I /5 normal in acute 
myelogenous leukemia). Some of the experiments pro-
duced curves which were the mirror image of the expected 
swelling curves, and we cannot explain these. 
Membrane changes observed 
Malignancy changes properties of the cell membrane. 
Ambrose found that if the membranes of fibroblasts from 
normal subjects touched , they formed an adhesion in the 
region of contact. Fibroblasts from patients with sarcoma 
lost this ability to form stable intercellular lesions. Sane! 
and Serpick studied monocytes from patients with acute 
monocytic or monomyelocytic leukemia . They found 
membrane bonding between cells by "zipperlike" junctions. 
The junctions exhibited reciprocal interdigita lions of plasma-
lemmal extrusions and areas of intimate contact between 
surface membranes of the adjoining cells. These areas of 
contact were different from sites of adhesion. They were 
larger and they showed a specialized architecture, consisting 
of facing, rigidly parallel membranes of the two cell 
surfaces separated by an electron-lucent space 150 to 200 
angstroms thick. If stained with uranyl acetate , the 
junctions appeared as two confronting trilaminar unit 
membranes separated by perpendicular, ladder-like inter-
cepts 30 to 50 angstroms in diameter, evenly spaced 90 
to I 00 angstroms apart. Sane! and Serpick surmised 
that "the induction or unmasking of unique, highly 
specialized structural complexes in these leukemic cells ... 
may be related to neoplastic modifications of the plasma 
membrane or its extraneous coat". The zipperlike 
junctions were found in vitro. The altered membrane 
bonding was not demonstrated in vivo, but it might occur. 
The high incidence of infection with Pseudomonas 
aeruginosa or similar organisms in leukemic patients is 
consistent with altered cell membranes in vivo. 
Kanno ( 1966) reported that such zipperlike junctions 
were associated with selective permeability. Therefore, 
altered membrane permeability might be expected in 
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monocytic or myelocytic leukemia. However, none of the 
above authors measured membrane permeability. 
Altered membrane glycoproteins could contribute 
to changes in permeability of outer and inner membranes 
of tumor cells. Such altered membrane glycoprotein 
has been reported by a number of workers. Klein 
et al. examined the lymphocytes of an 82-year-old male 
with chronic lymphocytic leukemia. They reported that 
cells from chronic lymphocytic leukemics have unusual 
surfaces. IgM heavy chain (mu chain) and kappa light chain 
immunoglobulins were found on the cell surfaces in 
amounts sufficient to be shown by fluorescein-labeled 
antibodies and fluorescence microscopy . About 80,000 
lgM molecules were present on each lymphocyte. Klein 
found no evidence that the immunoglobulins come from 
other sources than the leukemic cell itself. The leukemia 
cell synthesized its surface immunoglobulins. 1 f these 
molecules were located at sites where transmembrane 
movement occurred (as if they moved from cell interior 
to exterior through "pores") then their presence might 
help to explain an altered membrane permeability of 
lymphocytes from patients with leukemia. 
Preud 'Homme and Seligman studied lymphocytes from 
patients with leukemia. They found gamma-, kappa-, and 
lambda, and usually also mu-chain determinants on 
lumphocytes from patients with chronic lymphocytic 
leukemia. These determinants made the surfaces of 
these cells immunologically different from the surfaces 
of normal lymphocytes. 
Rubin and Schultz corroborated this finding. Further, 
they found a specific defect in ribosonal RNA processing 
in lymphocytes of patients with chronic lymphocytic 
leukemia. This reflected defective ''T" cells (thymus-
derived lymphocytes). They regarded chronic lymphocytic 
leukemia as a fundamental abnormality in lymphopoiesis. 
Holt et al., studied the surfaces of normal and leukemic 
lymphocytes from patients with chronic lymphocytic leuke-
mia. They found that the surface of the leukemic lympho-
cyte was considerably more resistant to ionic etching than 
normal cells. This was due to loss of the physical hardness 
and consequent increased resilence of the lymphocyte 
surface. This alteration of the properties of the surface was 
also evident from other measurements. They suggested 
that alteration of phospholipid metabolism may produce 
a micro-injury in the membrane and may be partly 
responsible for the observed weakness of the membrane of 
the leukemic lymphocyte. 
Thomson found that lymphocytes from patients with 
chronic lymphocytic leukemia were unusually resistant to 
hypotonic shock. This implies that the membrane perme-
ability to water was reduced. 
Burrows reported that lymphocytes from patients with 
chronic lymphocytic leukemia show decreased osmotic 
fragility. The time to lysis was increased over normal , 
indicating decreased membrane permeability to water. 
Hemplin reported that normal human leukocytes had 
values of the osmotic filtration coefficient (L p) of 
0.83 microns per minute per atmosphere . Leukocytes 
from patients with leukemias had the following significantly 
different values for L p chronic lymphocytic 
leukemia: 0.57;, acute myelogenous leukemia: 0.47; 
chronic myelocytic leukemia : 0.45. He found that the 
following factors affected the value of L p : age of donor, 
volume of the cell, volume of osmotically inactive material 
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in the cell, and % granulocytes in the granulocyte-lympho-
cyte mixture. Hempling did not report examining erythro-
cytes. 
Solomon has associated the water permeability with a 
pore size . This drop in permeability in leukemia can be 
interpreted as a dramatic decrease in membrane pore size. 
It raises the following questions: 
In which cell is pore size changed? 
In which leukemias is pore size changed? 
Does pore size decrease in cell leukemias? 
If so, does it affect the progress of the disease? 
When, in the course of the leukemia, does the pore 
size decrease? 
In order for an anti-leukemia drug to be effective, 
must it be less than a certain critical size to enter 
the cell? 
Would entrance of the drug be potentiated by 
another drug which may increase membrane 
permeability? 
The answers to these questions await further research. 
The composition of the cell suspension solutions and of 
the challenging solutions varied from laboratory to labora-
tory. No protein was present in the cell resuspension medium 
or the challenging solution in most cases. Cells may 
crenate in the absence of protein in solution, even if the 
solution is isotonic. Other workers usually determined the 
value of the osmotic filtration coefficient from a few 
samples of cells. 
In the reports found, it was not clear if the cells were 
taken from patients prior to the initiation of chemo- or 
radiation therapy, during, or after therapy, or in remission. 
If the value of membrane permeability changed during the 
course of the disease, the studies in the literature did not 
monitor these changes. Rather, any such changes would 
appear as excess variation in the measured value of 
membrane permeability. The sampling schedule should be 
coordinated with the treatment schedule, and permeability 
measurements need to be interpreted in the context of the 
patient's clinical status. 
Combined with the other appropriate tests, the measure-
ments of the cei'l membrane permeability might supply 
useful information in the treatment of certain leukemias, 
as giving diagnostic evidence for monitoring these effects of 
drugs on the cells, predicting the effectiveness of drugs on 
the patient's disease , or predicting the onset of a leukemic 
crisis. 
Osmotic filtration measured 
We applied the technique to detecting a change from the 
normal value of the osmotic filtration coefficient of the 
cell membrane associated with acute leukemias. The value 
of the osmotic filtration coefficient was measured for 
erythrocytes from leukemic patients. The results from these 
measurements indicated a decrease in the osmotic filtration 
coefficient of erythrocyte membranes from patients with 
acute leukemias. The values were significantly decreased 
below normal. This finding is not inconsistent with the 
hypothesis that disease effects the function and structure of 
the cell membrane. The procedure may be helpful to the 
oncologist; for example, in the selection of drug-responsive 
patients. The procedure might enable the evaluation of the 
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